Induction of Apoptosis and Growth-Inhibition by Thymoquinone in ACHN and GP-293 Cell Lines in Comparable with Cis-Platinum. 2019

Samira Shahraki, and Reza Mohebbati, and Mohammad Naser Shafei, and Mahmoud Mahmoudi, and Sara Hosseinian, and Soghra Parhizgar, and Zohreh Naji Ebrahimi Yazd, and Nazanin Entezari Heravi, and Reza Nejad Shahrokh Abadi, and Abolfazl Khajavirad
Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

OBJECTIVE In the current work, we investigated the cytotoxic and apoptotic effects of Thymoquinone (TQ), an active compound of Nigella sativa (N. sativa) and Cis-platinum, on normal renal epithelial (GP-293) and human renal adenocarcinoma cell lines (ACHN). METHODS GP-293 and ACHN cell lines were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% Fetal bovine serum (FBS) and 1% penicillin plus streptomycin antibiotic. The MTT assay was used for cellular viability assessment. Viability of cells was observed using inverted light microscope 24, 48 and 72 h after exposure of the cells to various concentrations of TQ (1, 2.5, 5, 10, 50 and 100 μg/ml) and Cis-platinum (0.5, 1, 1.5, 2, 3, 6 and 12.5 μg/ml). Moreover, apoptosis was analyzed with a flow-cytometry method. The untreated cells were considered as control group. RESULTS Morphological changes such as reduced cell number and increased intercellular distance and reduced cell viability in ACHN and GP-293cell lines were observed in both TQ and Cis-platinum groups; however, Cis-platinum had greater effect on ACHN cell line than GP-293 cell line. In addition, GP-293 cell line was more sensitive to TQ compared to ACHN cell line. Furthermore, TQ and Cis-platinum had apoptotic effects on both ACHN and GP-293 cell lines. CONCLUSIONS Our findings demonstrated that TQ and Cis-platinum had cytotoxic and apoptotic effects on both cell lines, However, GP-293 cell line was more sensitive to TQ. Additionally, Cis-platinum was more effective on ACHN cell line than on GP-293 cell line.

UI MeSH Term Description Entries

Related Publications

Samira Shahraki, and Reza Mohebbati, and Mohammad Naser Shafei, and Mahmoud Mahmoudi, and Sara Hosseinian, and Soghra Parhizgar, and Zohreh Naji Ebrahimi Yazd, and Nazanin Entezari Heravi, and Reza Nejad Shahrokh Abadi, and Abolfazl Khajavirad
January 2003, International journal of oncology,
Samira Shahraki, and Reza Mohebbati, and Mohammad Naser Shafei, and Mahmoud Mahmoudi, and Sara Hosseinian, and Soghra Parhizgar, and Zohreh Naji Ebrahimi Yazd, and Nazanin Entezari Heravi, and Reza Nejad Shahrokh Abadi, and Abolfazl Khajavirad
January 2023, Advanced biomedical research,
Samira Shahraki, and Reza Mohebbati, and Mohammad Naser Shafei, and Mahmoud Mahmoudi, and Sara Hosseinian, and Soghra Parhizgar, and Zohreh Naji Ebrahimi Yazd, and Nazanin Entezari Heravi, and Reza Nejad Shahrokh Abadi, and Abolfazl Khajavirad
November 1995, Journal of the National Cancer Institute,
Samira Shahraki, and Reza Mohebbati, and Mohammad Naser Shafei, and Mahmoud Mahmoudi, and Sara Hosseinian, and Soghra Parhizgar, and Zohreh Naji Ebrahimi Yazd, and Nazanin Entezari Heravi, and Reza Nejad Shahrokh Abadi, and Abolfazl Khajavirad
November 2022, International journal of molecular sciences,
Samira Shahraki, and Reza Mohebbati, and Mohammad Naser Shafei, and Mahmoud Mahmoudi, and Sara Hosseinian, and Soghra Parhizgar, and Zohreh Naji Ebrahimi Yazd, and Nazanin Entezari Heravi, and Reza Nejad Shahrokh Abadi, and Abolfazl Khajavirad
January 2016, Journal of traditional and complementary medicine,
Samira Shahraki, and Reza Mohebbati, and Mohammad Naser Shafei, and Mahmoud Mahmoudi, and Sara Hosseinian, and Soghra Parhizgar, and Zohreh Naji Ebrahimi Yazd, and Nazanin Entezari Heravi, and Reza Nejad Shahrokh Abadi, and Abolfazl Khajavirad
April 1998, Carcinogenesis,
Samira Shahraki, and Reza Mohebbati, and Mohammad Naser Shafei, and Mahmoud Mahmoudi, and Sara Hosseinian, and Soghra Parhizgar, and Zohreh Naji Ebrahimi Yazd, and Nazanin Entezari Heravi, and Reza Nejad Shahrokh Abadi, and Abolfazl Khajavirad
January 2009, Nutrition and cancer,
Samira Shahraki, and Reza Mohebbati, and Mohammad Naser Shafei, and Mahmoud Mahmoudi, and Sara Hosseinian, and Soghra Parhizgar, and Zohreh Naji Ebrahimi Yazd, and Nazanin Entezari Heravi, and Reza Nejad Shahrokh Abadi, and Abolfazl Khajavirad
May 2000, Leukemia,
Samira Shahraki, and Reza Mohebbati, and Mohammad Naser Shafei, and Mahmoud Mahmoudi, and Sara Hosseinian, and Soghra Parhizgar, and Zohreh Naji Ebrahimi Yazd, and Nazanin Entezari Heravi, and Reza Nejad Shahrokh Abadi, and Abolfazl Khajavirad
June 2005, Oncology reports,
Samira Shahraki, and Reza Mohebbati, and Mohammad Naser Shafei, and Mahmoud Mahmoudi, and Sara Hosseinian, and Soghra Parhizgar, and Zohreh Naji Ebrahimi Yazd, and Nazanin Entezari Heravi, and Reza Nejad Shahrokh Abadi, and Abolfazl Khajavirad
March 1997, International journal of cancer,
Copied contents to your clipboard!